| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 1, 2026 | Tax withholding(F) | 3K | $48.13 | $154K | 32K |
| Apr 1, 2026 | Option exercise(M) | 8K | — | — | 35K |
| Jan 15, 2026 | Grant(A) | 372 | $24.16 | $9K | 27K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Apr 1, 2026 | Grant(A) | 7K | — | $0 | 7K |
| Apr 1, 2026 | Option exercise(M) | 3K | — | $0 | 3K |
| Apr 1, 2026 | Option exercise(M) | 2K | — | $0 | 5K |
| Apr 1, 2026 | Option exercise(M) | 3K | — | $0 | 8K |
| Apr 1, 2026 | Grant(A) | 15K | — | $0 | 15K |
| Apr 1, 2026 | Grant(A) | 4K | — | $0 | 4K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001464583-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Kiniksa Pharmaceuticals International, plc
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.